Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing <i>Pseudomonas aeruginosa</i>
dc.contributor.author | Soto, Katherine D. | |
dc.contributor.author | Alcalde-Rico, Manuel | |
dc.contributor.author | Ugalde, Juan A. | |
dc.contributor.author | Olivares-Pacheco, Jorge | |
dc.contributor.author | Quiroz, Valeria | |
dc.contributor.author | Brito, Barbara | |
dc.contributor.author | Rivas, Lina M. | |
dc.contributor.author | Munita, Jose M. | |
dc.contributor.author | Garcia, Patricia C. | |
dc.contributor.author | Wozniak, Aniela | |
dc.date.accessioned | 2025-01-20T16:15:30Z | |
dc.date.available | 2025-01-20T16:15:30Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Introduction Ceftazidime/avibactam (CZA) is indicated against multidrug-resistant Pseudomonas aeruginosa, particularly those that are carbapenem resistant. CZA resistance in P. aeruginosa producing PER, a class A extended-spectrum beta-lactamase, has been well documented in vitro. However, data regarding clinical isolates are scarce. Our aim was to analyze the contribution of PER to CZA resistance in non-carbapenemase-producing P. aeruginosa clinical isolates that were ceftazidime and/or carbapenem non-susceptible. Methods Antimicrobial susceptibility was determined through agar dilution and broth microdilution, while bla(PER) gene was screened through PCR. All PER-positive isolates and five PER-negative isolates were analyzed through Whole Genome Sequencing. The mutational resistome associated to CZA resistance was determined through sequence analysis of genes coding for PBPs 1b, 3 and 4, MexAB-OprM regulators MexZ, MexR, NalC and NalD, AmpC regulators AmpD and AmpR, and OprD porin. Loss of bla(PER-3) gene was induced in a PER-positive isolate by successive passages at 43 degrees C without antibiotics. Results Twenty-six of 287 isolates studied (9.1%) were CZA-resistant. Thirteen of 26 CZA-resistant isolates (50%) carried bla(PER). One isolate carried bla(PER) but was CZA-susceptible. PER-producing isolates had significantly higher MICs for CZA, amikacin, gentamicin, ceftazidime, meropenem and ciprofloxacin than non-PER-producing isolates. All PER-producing isolates were ST309 and their bla(PER-3) gene was associated to ISCR1, an insertion sequence known to mobilize adjacent DNA. PER-negative isolates were classified as ST41, ST235 (two isolates), ST395 and ST253. PER-negative isolates carried genes for narrow-spectrum beta-lactamases and the mutational resistome showed that all isolates had one major alteration in at least one of the genes analyzed. Loss of bla(PER-3) gene restored susceptibility to CZA, ceftolozane/tazobactam and other beta-lactamsin the in vitro evolved isolate. Discussion PER-3-producing ST309 P. aeruginosa is a successful multidrug-resistant clone with bla(PER-3) gene implicated in resistance to CZA and other beta-lactams. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.3389/fcimb.2024.1410834 | |
dc.identifier.issn | 2235-2988 | |
dc.identifier.uri | https://doi.org/10.3389/fcimb.2024.1410834 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/90498 | |
dc.identifier.wosid | WOS:001250656000001 | |
dc.language.iso | en | |
dc.revista | Frontiers in cellular and infection microbiology | |
dc.rights | acceso restringido | |
dc.subject | Pseudomonas aeruginosa | |
dc.subject | blaPER-3 gene | |
dc.subject | PER-3 extended-spectrum beta-lactamase | |
dc.subject | ceftazidime/avibactam resistance | |
dc.subject | mutations conferring CZA resistance | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing <i>Pseudomonas aeruginosa</i> | |
dc.type | artículo | |
dc.volumen | 14 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ceftazidime avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing Pseudomonas aeruginosa.pdf
- Size:
- 1.85 MB
- Format:
- Adobe Portable Document Format
- Description: